Trifluoroacetic acid → HCID 59435996, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[C:4]([Cl:9])[C:3]=1[N:10](COCC[Si](C)(C)C)[C:11]1[C:20]2[CH:19]=[CH:18][N:17](COCC[Si](C)(C)C)[C:16](=[O:29])[C:15]=2[C:14]2[CH:30]=[C:31]([N:34]3[CH2:39][CH2:38][O:37][CH2:36][CH2:35]3)[CH:32]=[CH:33][C:13]=2[N:12]=1.C(O)(C(F)(F)F)=O>ClCCl>[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[C:4]([Cl:9])[C:3]=1[NH:10][C:11]1[C:20]2[CH:19]=[CH:18][NH:17][C:16](=[O:29])[C:15]=2[C:14]2[CH:30]=[C:31]([N:34]3[CH2:39][CH2:38][O:37][CH2:36][CH2:35]3)[CH:32]=[CH:33][C:13]=2[N:12]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 5-((2,6-dichloro-4-fluorophenyl){[2-(trimethylsilyl)ethoxy]methyl}amino)-9-morpholin-4-yl-2-{[2-(trimethylsilyl)ethoxy]methyl}benzo[c]-2,6-naphthyridin-1(2H)-one (58 mg, 0.08 mmol) in dichloromethane (3 mL) was added TFA (2 ml) and the mixture was stirred at room temperature for 2.5 h. The solvents were evaporated and the residue was dissolved in MeOH, filtered and purified by reverse phase HPLC to afford the title compound.
Workup
- customThe solvents were evaporated
- dissolutionthe residue was dissolved in MeOH
- filtrationfiltered
- custompurified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-dfee48b3eda644728ca8b7f9d4355945
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08349865B2
Reaction notes
Loading…